Updated:
Avego Bioscience Capital
Avego Bioscience Capital is a venture capital firm. It has invested $416 million across three deals.
Avego Bioscience Capital
Avego Bioscience Capital is a venture capital firm. It has invested $416 million across three deals. Its focus areas include biotechnology and manufacturing.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Additional offices
Boston · New York · Dallas · White Plains · Philadelphia · Los Angeles · San Francisco · Chicago
Sector focus
Frequently asked questions
What stage does Avego Bioscience Capital typically invest at?
Avego focuses on early-stage bioscience companies, with an emphasis on seed and Series A rounds. Its office network in research-dense cities suggests a model that engages with academic spinouts and pre-clinical therapeutics developers.
Where does Avego Bioscience Capital maintain offices?
The firm lists offices in London, Boston, New York, Dallas, White Plains, Philadelphia, Los Angeles, San Francisco, and Chicago, per its public registrations. This transatlantic footprint is unusually broad for a specialist bioscience investor.
Does Avego Bioscience Capital invest in therapeutics or digital health?
The firm's mandate covers both therapeutics and digital health, operating at the intersection of biology and computation. Its presence in San Francisco supports exposure to computational biology and AI-driven drug discovery startups, while its East Coast and Texas offices connect it to traditional biotech and clinical research hubs.
Who runs investment decisions at Avego Bioscience Capital?
The firm has not publicly disclosed its investment committee or managing partners. Its distributed office structure may indicate either a network of venture partners or a lean central team supported by regional scientific advisors.
How does Avego Bioscience Capital source its deals?
Deal flow likely originates through relationships with academic technology transfer offices, PI-led research labs, and syndicate partners in Boston and the UK. The firm's London headquarters and US office network provide coverage of both the Golden Triangle and the major US biotech corridors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: